China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized controlled, open label clinical study of IL-1 inhibitor combined with febuxostat in the treatment of chronic gouty stone arthritis patients'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132644
Registration Time: 2026/09/16
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Ustcanhui Provincial Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340984
Published by HT Digital Content Services with permission from Health Daily Digest....